Meghana Keshavan from STAT News - Journalist Profile

	Profile	Recent Articles on Subject
1	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	GLP-1 drugs spark disagreements in Trump’s circle - 10 days ago Biopharma leaders lay out vision for the future of blood cancer treatment - 15 days ago STAT+: Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference - 15 days ago Sanofi pours $1 billion into China for insulin plant - 21 days ago Despite probe, China reimbursing AstraZeneca drug - 22 days ago The biotech news you need to read today - 27 days ago More beef in the gene editing space - about 1 month ago Versant enters obesity with new startup - about 1 month ago A win for Apellis, a setback for Astellas - about 1 month ago Risk of aspiration during surgery added to GLP-1 drug labels - about 1 month ago The biotech news roundup to start your week - about 2 months ago A setback for the tau approach to Alzheimer’s - about 2 months ago The biotech news you need to read today - about 2 months ago STAT+: Potential competition for RSV prophylactic Beyfortus - 2 months ago Eli Lilly releases new data on weekly insulin - 3 months ago Lilly has more positive data on its weekly insulin - 4 months ago STAT+: Rick Doblin, ‘unleashed,’ blasts FDA over Lykos drug rejection and turns to global push for MDMA therapy - 4 months ago Is pharma still fearful of the Inflation Reduction Act? - 4 months ago STAT+: Lykos Therapeutics cuts 75% of staff after FDA rejects MDMA-assisted therapy - 4 months ago A tough week for MDMA-assisted psychotherapy - 4 months ago STAT+: Three MDMA therapy papers retracted over data integrity concerns - 4 months ago FDA rejects MDMA as a psychedelic treatment for PTSD - 5 months ago STAT+: Why did Novo pull heart failure paperwork for Wegovy? - 5 months ago Element Biosciences raises another massive round - 5 months ago The biotech news you missed this week - 6 months ago Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy? - 6 months ago STAT+: More tumult at BIO amid the company’s fourth CEO in four years - 7 months ago ICER casts doubt on Sarepta’s DMD gene therapy - 8 months ago The latest updates on cancer research from the weekend - 9 months ago Sanofi resolves most Zantac litigation - 9 months ago How resurrecting extinct species might impact medicine - 9 months ago New data on liquid biopsy for colorectal cancer detection still underwhelms - 9 months ago Lawmakers want to add more Chinese biotechs to defense list - 9 months ago How GLP-1’s moved from research labs to national TV - 9 months ago How will the Supreme Court’s mifepristone decision impact biopharma? - 9 months ago EU adviser says Illumina merger was not problematic - 9 months ago What happens when an approved drug doesn’t work? - 9 months ago Eli Lilly’s anti-vanity ad campaign for Oscars - 10 months ago Serum Institute of India wants government HPV contract - 10 months ago Despite good data, Ironwood’s shares plummet - 10 months ago What do CEOs owe the world? - 10 months ago Replicate’s srRNA rabies vaccine effective in Phase 1 - 10 months ago The need to know biotech news stories today - 10 months ago Psychedelic investment continues to ramp up - 11 months ago Does Moderna’s RSV vaccine lose efficacy faster than others? - 11 months ago Regeneron is interested in obesity treatments that combat muscle loss - 11 months ago 23andMe breach targeted Chinese, Jewish populations - 11 months ago The Senate health committee looks into its first subpoena in 40 years - 11 months ago Novartis reportedly decides to pass on Cytokinetics - 12 months ago Why did Allogene cancel two clinical trials for its off-the-shelf cell therapy? - 12 months ago
2	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	Biopharma leaders lay out vision for the future of blood cancer treatment - 15 days ago
3	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	Biopharma leaders lay out vision for the future of blood cancer treatment - 15 days ago
4	Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California BiotechLife SciencesImmunology	Biopharma leaders lay out vision for the future of blood cancer treatment - 15 days ago
5	Olivia Goldhill STAT News	FDA rejects MDMA as a psychedelic treatment for PTSD - 5 months ago